121 unknown, 74 completed, 36 recruiting, 23 not yet recruiting. 101 Not applicable, 19 Phase 4, 16 Phase 3, 13 Phase 1, 11 Early Phase 1.
Follow Shanghai 10th People's Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Transcranial Electrical Stimulation for Comorbid Depression and Chronic Pain tDCS, alpha-tACS, Sham - Depression Disorder, Chronic Pain | Not applicable | Recruiting | Shanghai Mental Health Center | 160 | 2026-11-01 | 2026-09-04 |
| Mazdutide for Weight Management and Gout in Adults With Obesity Mazdutide - Gout, Obesity (BMI>30) | Phase 4 | Not yet recruiting | Hongwei Jiang | 30 | 2026-09-15 | 2026-09-17 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma Celecoxib + Pembrolizumab + Gemcitabine/Cisplatin, Pembrolizumab + Gemcitabine/Cisplatin - Intrahepatic Cholangiocarcinoma (Icc) | Phase 1 / Phase 2 | Not yet recruiting | Shanghai 6th People's Hospital | 112 | 2026-09-15 | 2026-08-28 |
| A Multicenter Clinical Study on Protein Absorption Efficiency in Patients With Pancreatic Exocrine Insufficiency in the ICU Short peptide, Protein - High-risk Patients With Pancreatic Exocrine Insufficiency, Enteral Nutrition Feeding | Phase 4 | Not yet recruiting | Shanghai 10th People's Hospital | 250 | 2026-07-01 | 2026-07-16 |
| Evaluating the Diagnostic Performance and Impact on Clinical Outcomes of the NuRapid-CRISPR Pathogen Profile Assay in ICU Patients With Sepsis NuRapid-CRISPR Rapid Pathogen Detection Technology, Traditional pathogen culture - Sepsis | Not applicable | Not yet recruiting | Shanghai 10th People's Hospital | 396 | 2026-07-01 | 2026-05-12 |
| Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction Intravascular Ultrasound, Coronary angiography guidance - STEMI, PCI | Not applicable | Not yet recruiting | Shanghai Zhongshan Hospital | 2488 | 2026-06-01 | 2026-06-18 |
| A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia Administer Romiplostim treatment., Administer recombinant human thrombopoietin therapy - Sepsis | Phase 1 | Not yet recruiting | Shanghai 10th People's Hospital | 280 | 2026-06-01 | 2026-05-19 |
| Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients amino acid (15) peritoneal dialysis solution - End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD) | Phase 4 | Enrolling by invitation | Shanghai 10th People's Hospital | 50 | 2026-05-01 | 2026-04-28 |
| An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection Guselkumab - Crohn's Disease (CD) | Not yet recruiting | Shanghai 10th People's Hospital | 88 | 2026-04-15 | 2026-04-14 | |
| FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer Standard First-Line Therapy, FMT Combined with Standard First-Line Therapy - Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic) | Phase 2 / Phase 3 | Not yet recruiting | Shanghai 10th People's Hospital | 220 | 2026-04-01 | 2026-04-03 |
| Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke Human Adipose-Derived Stem Cell Exosomes, Placebo - Acute Ischemic Stroke | Phase 1 / Phase 2 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 60 | 2026-01-31 | 2026-02-10 |
| A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC Adebrelimab (PD-L1 inhibitor) - Small Cell Lung Cancer (SCLC) | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 500 | 2026-01-27 | 2026-02-25 | |
| Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease Infliximab, Adalimumab, Vedolizumab - Inflamatory Bowel Disease, Crohn Disease (CD) | Recruiting | Shanghai 10th People's Hospital | 198 | 2026-01-16 | 2026-07-10 | |
| Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. Coenzyme I for Injection, NaCl (placebo) - Vascular Aging, NAD | Not applicable | Not yet recruiting | Shanghai 10th People's Hospital | 60 | 2026-01-16 | 2026-01-08 |
| Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension Renal Denervation, Renal Angiography - Hypertension, Renal Denervation Therapy | Not applicable | Not yet recruiting | Shanghai 10th People's Hospital | 124 | 2026-01-01 | 2026-02-02 |
| Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease pre-packaged low-residue diet for bowel preparation - IBD (Inflammatory Bowel Disease), Colonoscopy | Not applicable | Recruiting | Changhai Hospital | 1000 | 2026-01-01 | 2026-05-14 |
| Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction Myocardial Infarction | Recruiting | Shanghai 10th People's Hospital | 50 | 2026-01-01 | 2026-08-14 | |
| Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia Spermidine, Placebo - Obesity & Overweight, Hyperlipidemia | Not applicable | Recruiting | Shanghai 10th People's Hospital | 50 | 2026-01-01 | 2026-06-23 |
| Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients Standard Pre-colonoscopy Bowel Preparation Protocol - IBD (Inflammatory Bowel Disease), Colonoscopy | Recruiting | Changhai Hospital | 1000 | 2025-12-08 | 2026-05-14 | |
| A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST GOLP regimen, Surgery, TDTP-RECIST - Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy | Not applicable | Not yet recruiting | Shanghai Zhongshan Hospital | 270 | 2025-12-01 | 2025-10-06 |
Showing 20 of 267. Sign in to see all of them.
Atrial Fibrillation (14) · Polycystic Ovary Syndrome (14) · Obesity (11) · Crohn Disease (8) · Colorectal Neoplasms (7) · Coronary Artery Disease (7) · Diabetes Mellitus (7) · Ischemic Stroke (7) · Heart Failure (6) · Hypertension (6) · Hyperuricemia (6) · Carcinoma, Non-Small-Cell Lung (5) · Emergence Delirium (5) · Inflammatory Bowel Diseases (5) · Myocardial Infarction (5)
Fecal Microbiota Transplantation (7) · Metformin (7) · Probiotics (6) · Infliximab (4) · Left Atrial Appendage Closure (3) · Sodium-Glucose Transporter 2 Inhibitors (3) · Surgical Procedures, Operative (3) · Tenecteplase (3) · Alprostadil (2) · Aspirin (2) · Azathioprine (2) · Benzbromarone (2) · Caloric Restriction (2) · Cisplatin (2) · Cryosurgery (2)
China (236) · United States (1)
Shen Qu, Dr (8) · Huanlong Qin (4) · Yuan Shen, MD, PhD (4) · Manna Zhang, doctor (3) · Ya-Wei Xu, MD, FACC (3) · Yawei Xu, MD, PhD (3) · Yawei Xu, PhD (3) · Yidong Wei, M.D., Ph.D. (3) · Ai Peng, MD, PhD (2) · Cheng-Le Zhuang, MD, PhD (2) · Da Fu, PhD (2) · Ling Wang, MD, PhD (2) · Xinying Wang, MD (2) · Yawei Xu (2) · Yawei Xu, M.D., Ph.D. (2)
PMID 25651787, PMID 37300882, PMID 38369126, PMID 40497495, PMID 41446320, PMID 10607766, PMID 12842534, PMID 14605078, PMID 15187010, PMID 16039180, PMID 17157949, PMID 17273960, PMID 17525256, PMID 19418401, PMID 19679250, PMID 20394883, PMID 22032711, PMID 22145843, PMID 22516383, PMID 22922562, PMID 23165340, PMID 23278227, PMID 23594859, PMID 23797811, PMID 23924602, PMID 24011928, PMID 24405824, PMID 24551879, PMID 24552184, PMID 24650395, PMID 24745612, PMID 24841547, PMID 24999798, PMID 25391758, PMID 25592946, PMID 25805059, PMID 25926349, PMID 26171002, PMID 26289708, PMID 26304958, PMID 26531676, PMID 26854971, PMID 27109174, PMID 27827332, PMID 28219916, PMID 28304224, PMID 28360242, PMID 28376799, PMID 28389860, PMID 28528875